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        My association with the   JCB   began very 
early in my scientiﬁ   c career. In fact, it 
predated my understanding that there 
would even be a scientiﬁ  c career. In the 
mid-1970s while still an undergraduate, 
the   JCB   published my very ﬁ  rst paper, a 
contribution noted perhaps less so for its 
reporting the characterization of the ﬁ  rst 
known protein in plant cell walls than for 
a footnote that called attention to the 
evolutionary conservation of a relation-
ship between “sex and slime” throughout 
the plant and animal kingdoms. 
  Some years later, while a junior faculty 
member at Yale, I was invited to join the 
  JCB   Editorial Board by the journal  ’  s 
then Editor-in-Chief, the late Bernie 
Gilula, who was head of cell biology at 
Scripps. After serving a couple of terms I 
  “  retired,  ”   only to be recruited once again 
by Bernie, this time to serve as one of the 
journal  ’  s senior editors. Within months, I 
was asked by my fellow senior editors 
to accept the post of Editor-in-Chief. 
Bernie was stepping down after a long 
tenure at a time of transition at the 
Rockefeller University, a new President 
(Arnie Levine) having just been ap-
pointed. Because New Haven was close 
to New York, and because I was a Rock-
efeller expatriate, I was viewed as being 
in an optimal situation to serve as liai-
son. I accepted the position for one year. 
  One year became two, then three, 
and now it is 10. It became clear early in 
my tenure that there were tumultuous 
times ahead for scientifi  c  publishing 
with the advent of the   “  open access  ”   
movement, the development of online 
publishing, and the aggressive expan-
sion of large commercial publishers, a 
development that has increasingly con-
solidated the control of scientifi  c com-
munication in the hands of for-profi  t 
corporations. It is not that these devel-
opments were necessarily bad (e.g., 
making scientifi  c information more ac-
cessible to the public), but they did indi-
vidually and collectively present a 
challenge to the   JCB ’ s   model of a not-
for-profi  t journal run by and for scien-
tists. This is a model that has no agenda 
other than a commitment to providing 
the highest quality and most infl  uential 
forum for scientifi  c exchange in the in-
creasingly broad fi  eld of cell biology. 
  Those dozens of us who have 
served the journal over the years believe 
the way to accomplish the   JCB ’ s   mis-
sion is to favor substance over style, to 
rely on practicing scientists as editorial 
arbiters, and to operate a peer-review 
process that is rigorous but fair, consis-
tent, and logical, with the goal of treat-
ing every submission as we would hope 
to have our own submissions handled. 
These basic tenets have served the   JCB , 
and the scientifi  c  community,  exceed-
ingly well since the journal  ’  s inception, 
establishing the   JCB   as a prestigious 
  “  journal of record  ”   in the broad fi  eld of 
cell biology. However, things do change, 
with the events of the last decade having 
revolutionized the landscape of scien-
tifi  c publishing and communication. The 
  JCB   also had to change to protect its 
very survival as a major journal in a 
competitive environment of   “  name 
brands ”   run  by  multinational  publishers 
with deep pockets. Where there was 
once just the   JCB   and   EMBO Journal  
(both scientist-run not-for-profi  ts), there 
is now   Nature Cell Biology ,   Develop-
mental Cell ,   Molecular Cell  , and   Cur-
rent Biology   that have joined the 
competition for excellent papers  —  and 
citations — in  cell  biology. 
  What did we do to adapt? When I 
began as Editor-in-Chief, I inherited a 
journal with a stellar reputation for ex-
cellence, but also one that was rather 
staid, conservative, and relatively nar-
row in scope. It was also operationally 
ineffi  cient, with most of the community 
(rightly) feeling that our publication 
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process was slow and frustrating. Led 
by Mike Rossner, who was then Execu-
tive Editor (now Director of The Rock-
efeller University Press), we revamped 
our procedures, continued the process 
of centralizing editorial operations in 
our New York offi   ce, initiated a new 
rapid publication route (  JCB   Reports), 
and concentrated decision making and 
reviewing to the senior editors and edi-
torial board members. Review times 
now are the best in the business, below 
30 days for a fi  rst decision, 3 days for 
editorial rejections, and less than a 
month from time of acceptance to time 
of   “  offi   cial ”   publication.  We  also  de-
cided to make the online version rather 
than the paper version of the   JCB   the 
actual   “ journal  of  record ”  — the  fi  rst 
journal to do so. We now provide exem-
plary service to the community with our 
excellent staff of professional editors 
(led by Emma Hill and Aimee deCathe-
lineau) providing superb and effi  cient 
support to our scientist-editors, and in-
creasingly serving with Mike as the 
journal  ’  s public face. I believe having 
such a public face is essential to ensure 
the   JCB ’ s   visibility to prospective au-
thors. Although   JCB   editors are almost 
always in attendance and major partici-
pants in any signifi  cant meeting any-
where in the world, they attend as 
scientists fi   rst and editors second (or 
third). Emma, Aimee, and Mike and 
their team increasingly ensure that the 
  JCB ’ s   interests are represented. 
  We broadened the scope of the 
journal  ’  s content, now spanning the 
breadth of cell biology more effectively. 
We added a few but highly successful 
features to the   “  front material  ”   of the 
journal to better highlight our content. 
We turned over nearly 50% of the senior 
editors to provide better scientifi  c, geo-
graphic, and gender balance. 
  We have led the movement for 
public access to scientifi  c content. Years 
before the advent of PLoS, we were the 
fi  rst major journal to release for free all 
of its content six months after publica-
tion (  Hill, 2007  ). We have also pioneered 
the application of   “  Creative Commons  ”   
licensing to the content of a subscrip-
tion-based journal  —    JCB   readers can 
freely reuse any of the journal  ’  s content 
for noncommercial purposes (  Hill and 
Rossner, 2008  ). We took our responsibil-
ities as public advocates quite seriously 
in these matters. I still fi  nd it diffi  cult to 
understand, however, why organizations 
such as the Howard Hughes Medical In-
stitute (HHMI) decided to pay profi  table 
commercial publishers for providing 
these services, which we had long pro-
vided for free (  Rossner and Mellman, 
2007  ). This was not, and is not, helpful 
to the cause of public access. Perhaps 
with the recent leadership change at 
HHMI, this situation will also change. 
  Another challenge that emerged 
following the move to electronic work 
fl  ow was data integrity, an issue that had 
not been adequately addressed by the 
scientifi  c community and largely ignored 
by publishers and journals. Again taking 
a public advocacy role, we developed 
standards for data representation (  Wade, 
2006  ), communicated them, and began 
routinely screening all accepted manu-
scripts for inappropriate manipulations 
of digital image data, years before the 
Hwang case broke; our procedures would 
have detected anomalies in this rather in-
famous stem cell paper (  Rossner and 
Yamada, 2004  ). Similarly, our new   JCB 
DataViewer   module allows readers to 
examine digital microscopy fi   les as if 
they were their own, further enabling 
scientifi  c communication of 3D informa-
tion using 2D media (  Hill, 2008  ). 
  How have we done? Our reputation 
appears intact, our submissions continue 
to rise, and our acceptance rate continues 
to fall (currently at an incredibly selec-
tive   15%). We have seen a slight down-
ward drift in that famously bogus metric, 
the   “ Impact  Factor, ”   most  likely  because 
of the increased competition for a lim-
ited number of papers in our fi  eld, and 
because the   JCB   has been unwilling to 
game the system as have others by se-
verely limiting the number of papers 
published, providing a steady stream of 
easily citable reviews, and perhaps even 
adjusting the actual data ex post facto. 
For example, the   JCB   publishes more 
papers per year than   Nature Cell Biology  
and   Developmental Cell   combined,  in-
creasing our all important   “  denominator  ”   
by 2.5-fold. We engaged Thomson 
Scientifi  c on these issues last year rather 
publicly, and their response was as in-
substantial and inaccurate as their metric 
(  Rossner et al., 2007  ,   2008  ). Yet, many 
scientists are infl  uenced by impact fac-
tors, as well as by name branding, be-
cause we scientists have allowed such 
matters to infl  uence hiring, promotion, 
and granting decisions. If we allowed 
ourselves to be infl  uenced by quality as 
determined, for example, by the half-
lives of citations,   JCB   (at 8.8 years) 
would be at the top of the list, ahead of 
  Cell ,   Nature ,  and   Science .  Papers  that 
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are infl  uential are those that continue to 
be cited for years! 
  What can we do? The   JCB   will 
and must increase its visibility and de-
sirability by playing to our inherent 
strengths: the commitment and support 
of a large cadre of dedicated scientist-
editors, authors, and readers. We remain 
one of the very last major journals that 
truly is run by scientists for scientists, 
which means that in the end, our inter-
ests are wholly aligned with the commu-
nity we serve. Our editors are the ones 
who (during their   “  day jobs  ”  ) set scien-
tifi  c agendas, organize meetings, make 
hiring decisions, and review each other  ’  s 
grants and papers. We cannot bequeath 
these responsibilities to others, which is 
effectively what happens if we allow 
ourselves to chase impact factors in 
making decisions about publication, hir-
ing, and the like. 
  But, challenged by the increased 
competition, the   JCB   must respond and 
not just complain. We need to continue 
improving our content and its presenta-
tion; this is the positive aspect of being 
challenged by worthy competitors. We 
need to continue to build on our commit-
ment to excellence, excitement, and pub-
lic advocacy. We also need to reach out 
more effectively to the next generation 
of scientists, the postdocs and students 
who are really the ones who will deter-
mine the future of science. For all these 
reasons, I decided some time ago (long 
before I decided to move to Genentech) 
that it was time in this year of change 
and hope, to pass the baton to a new 
Editor-in-Chief. Tom Misteli is the perfect 
choice: a generalist, an excellent scien-
tist, and enthusiastic supporter of science 
and the   JCB  . Look for many, many new 
initiatives that we hope will seize ever 
more attention in our community. One 
will come later in 2009, when Tom and I 
plan to host a special   JCB    Symposium  
for new and newer scientists, which if 
successful, will be a regular and highly 
prized series hosted by   JCB   editors. 
  It has been a high honor for me to 
lead the   JCB   for the past decade. Not 
only has it been a thrilling challenge and 
a serious responsibility, but it has been a 
joy to work ever so closely with some of 
the best scientists I have ever known, and 
to discuss matters of science and cell bi-
ology with a depth and degree of excite-
ment that is inspiring on a daily basis. 
The best path to success is to surround 
yourself with people far better than you, 
and that is precisely what I have done at 
the   JCB  , and why it has been such a priv-
ilege to take a turn at the helm. 
 And to Tom, in the words of Captain 
Jack Sparrow:   “  Bring on that horizon!  ”   
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